首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1454169

全球幽门螺旋桿菌诊断市场规模、份额、成长分析、最终用途、诊断测试、技术 - 产业预测，2024-2031 年

Global Helicobacter pylori H. pylori Diagnostics Market Size, Share, Growth Analysis, By End use(Hospital, Clinics), By Diagnostic Tests(Blood test, stool test), By Technology(Immuno diagnostic, Molecular diagnostic) - Industry Forecast 2024-2031

出版日期: 2024年03月09日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球幽门螺旋桿菌诊断市场规模估值为5.8768亿美元，从2023年的6.23亿美元增长到2031年的9.9372亿美元，预计在预测期内增长（2024年-预计复合年增长率为6.01） 2031 年的百分比）。

幽门螺旋桿菌 (H. pylori) 诊断的日益普及代表着医疗保健领域的重要进步，可提供改进的诊断、有效的治疗和降低成本。透过诊断检测及时检测病菌感染对于阻止疾病进展和最大限度地减少併发症起着至关重要的作用。这些测试可以准确识别胃和肠道中幽门螺旋桿菌的存在，使医疗保健专业人员能够及时启动适当的治疗，最终改善患者的治疗结果。早期疗育不仅可以缓解症状、加速溃疡癒合，还可以降低胃癌等严重併发症的风险。幽门螺旋桿菌诊断市场上提供的各种非侵入性诊断选项，包括血液检测、呼吸检测和粪便抗原检测，确保了患者的舒适度和可及性，同时保持了成本效益，从而将其适用性扩大到更多人。此外，从抗生素到降酸药物等多种治疗方法可为病菌感染提供高效的解决方案。透过有效处理这些感染疾病，患者不仅可以缓解症状，还可以避免溃疡和胃癌等潜在併发症，改善整体健康。有效的治疗策略还可以作为预防措施，预防消化性溃疡病的发生，消化性溃疡病是与幽门螺旋桿菌相关的常见併发症，可最大程度地减少导致衰弱症状和胃粘膜穿孔等严重后果的可能性。总体而言，幽门螺旋桿菌诊断和治疗的一体化强调了向主动医疗管理的模式转移，促进更好的健康结果和经济效益。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Abbott Laboratories
Allergan plc
AstraZeneca plc
Bayer AG
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Halyard Health, Inc.
Hologic, Inc.
Merck & Co., Inc.
Mylan NV
Pfizer, Inc.
Quidel Corporation
Sanofi SA
Seegene Inc.
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Trinity Biotech plc
ZEUS Scientific, Inc.

简介目录

Product Code: SQMIG35A2188

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 587.68 million in 2022 and is poised to grow from USD 623 million in 2023 to USD 993.72 million by 2031, growing at a CAGR of 6.01% during the forecast period (2024-2031).

The rise in popularity of Helicobacter pylori (H. pylori) diagnostics marks a significant advancement in healthcare, offering improved diagnosis, effective treatment, and cost reduction. Swift detection of H. pylori infections through diagnostic tests plays a pivotal role in halting disease progression and minimizing complications. These tests accurately identify the presence of the bacteria in the stomach or intestines, enabling timely initiation of appropriate treatment by healthcare providers, ultimately enhancing patient outcomes. Early intervention not only alleviates symptoms and accelerates ulcer healing but also mitigates the risk of severe complications, such as stomach cancer. The diverse array of non-invasive diagnostic options available in the H. pylori market, including blood, breath, and stool antigen tests, ensures patient comfort and accessibility while remaining cost-effective, thus extending their reach to a broader population. Furthermore, the plethora of treatment modalities, ranging from antibiotics to acid-reducing medications, offers highly efficacious solutions for combating H. pylori infections. By addressing these infections effectively, patients not only find relief from symptoms but also avert potential complications like ulcers and stomach cancer, thereby enhancing overall well-being. Effective treatment strategies also serve as a preventive measure against the development of peptic ulcers, a common complication associated with H. pylori, thus minimizing the occurrence of debilitating symptoms and serious outcomes like stomach lining perforation. Overall, the integration of H. pylori diagnostics and treatment underscores a paradigm shift towards proactive healthcare management, fostering better health outcomes and economic efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter pylori H. pylori Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter pylori H. pylori Diagnostics Market Segmental Analysis

Global Helicobacter pylori H. pylori Diagnostics market is segmented based on Diagnostic tests, technology, end-user, biomarker, and region. By end use, the Helicobacter pylori H. pylori Diagnostics Market is segmented into hospitals, clinics, research institutes, and others. By Diagnostic tests, the Helicobacter pylori H. pylori Diagnostics Market is segmented into Blood test, stool test, breath test, endoscopy, and others. By Technology, the Helicobacter pylori H. pylori Diagnostics Market is segmented into Immuno diagnostics, molecular diagnostics, Histology, and others. By region, the Helicobacter pylori H. pylori Diagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Helicobacter pylori H. pylori Diagnostics Market

The market for H. pylori thrives on the widespread prevalence of H. pylori infections worldwide, affecting an estimated half of the global population and ranking among the most prevalent bacterial infections. Consequently, there's an escalating demand for diagnostic tests and treatment solutions driven by the necessity for accurate diagnosis and effective management of the infection.

Restraints in the Global Helicobacter pylori H. pylori Diagnostics Market

The global market for H. pylori is buoyed by its widespread prevalence, with approximately half of the world's population affected by these infections, making it one of the most common bacterial infections globally. This prevalence fuels a growing demand for diagnostic tests and treatment options as healthcare systems strive to accurately diagnose and manage the infection effectively.

Market Trends of the Global Helicobacter pylori H. pylori Diagnostics Market

The market for H. pylori infection is experiencing a growing demand for non-invasive diagnostic methods like serology tests and urea breath tests. These alternatives are gaining popularity thanks to their minimal invasiveness and user-friendly design, driving a notable increase in their adoption.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Helicobacter pylori H. pylori Diagnostics Market by End use

Market Overview
Hospital
Clinics
research institutes and others

Global Helicobacter pylori H. pylori Diagnostics Market by Diagnostic Tests

Market Overview
Blood test
stool test
breath test
endoscopy and others

Global Helicobacter pylori H. pylori Diagnostics Market by Technology

Market Overview
Immuno diagnostic
Molecular diagnostic
Histology and others

Global Helicobacter pylori H. pylori Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halyard Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEUS Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments